Chronic high doses of thioacetamide followed by vitamin A modify dolichol, dolichol isoprenoids, and retinol content in rat liver cells.
Our line of researches follows the hypothesis that dolichol and retinol metabolism might be interrelated and involved in liver fibrosis. To this end, in this study rats were subjected to chronic treatment with thioacetamide (TAA) (300 mg/L liquid diet) for 1 and 2 months and, after liver damage had occurred, supplemented with vitamin A before sacrifice. Dolichol, dolichol isoprene units, and retinol content were determined in isolated parenchymal and sinusoidal liver cells (hepatic stellate cells; Kupffer cells; sinusoidal endothelial cells). Dolichol increased in hepatocytes after TAA treatment, with or without vitamin A. Dolichol decreased in the other cells. Retinol in general decreased. In hepatocytes, retinol decreased only on normal nutrition, while the vitamin A load was taken up normally. The percentages of dolichol isoprene units (Dol-16 to Dol-20, in rats) confirm that Dol-18, which was not modified in percentage by TAA on normal nutrition, did not increase after vitamin A, as it did in control cells (7-12%). The behavior of Dol-18 was similar in all the cells studied. Vitamin A might reveal a latent damage produced by TAA on dolichol homologues. These data support previous hypotheses that the action of TAA depends on the administration modality, the dosage, and the diet, and that Dol-18 might have different functions and compartmentalization in the cells. Furthermore, the results support the hypothesis that dolichol chain length might be interrelated with retinol metabolism, perhaps through their metabolites.
Bassi
Anna Maria
AM
Section of General Pathology, Department of Experimental Medicine, University of Genoa, Genoa, Italy. ambassi@medicina.unige.it
Casu
Anna
A
Canepa
Claudio
C
Maloberti
Giuseppe
G
Nanni
Giorgio
G
D000284:Administration, Oral; D000818:Animals; D002469:Cell Separation; D002851:Chromatography, High Pressure Liquid; D004032:Diet; D004286:Dolichols / Q000378:metabolism*; D004359:Drug Therapy, Combination; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008106:Liver Cirrhosis, Experimental / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D008136:Longevity / Q000187:drug effects; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D013729:Terpenes / Q000378:metabolism; D013853:Thioacetamide / Q000633:toxicity*; D014801:Vitamin A / Q000008:administration & dosage* / Q000378:metabolism*
D004286:Dolichols; D013729:Terpenes; D013853:Thioacetamide; D014801:Vitamin A